Skin News and Research

RSS

Rexceptor receives exclusive license for novel treatment of Alzheimer's disease

Case Western Reserve's Technology Transfer Office has granted an exclusive license of a novel Alzheimer's Disease (AD) treatment strategy to spinoff company ReXceptor Inc., which plans to initiate early-stage human clinical trials of the medication within the next few months.

26 Apr 2013

Microbial population in New York City subway system is nearly identical to that of ambient air on city streets

The microbial population in the air of the New York City subway system is nearly identical to that of ambient air on the city streets. This research, published ahead of print in the journal Applied and Environmental Microbiology, establishes an important baseline, should it become necessary to monitor the subway's air for dispersal of potentially dangerous microbes.

25 Apr 2013

Caliper test reliable for feet

Two-point discrimination using mechanical calipers is a reliable assessment for testing tactile acuity of the foot, demonstrates research published in Rheumatology.

25 Apr 2013

Transcranial magnetic stimulation benefits in Parkinson’s disease

A course of low-frequency repetitive transcranial magnetic stimulation delivered over the supplementary motor area improves motor symptoms in patients with Parkinson’s disease, shows results from a randomized controlled trial.

25 Apr 2013

Symposium presentation highlights pioneer of gastrointestinal research

A fur trader who suffered an accidental gunshot wound in 1822 and the physician who saw this unfortunate incidence as an opportunity for research are key to much of our early knowledge about the workings of the digestive system, say speakers of an upcoming symposium.

25 Apr 2013

Hospital for Special Surgery receives grant for new genomics center to study autoimmune diseases

Hospital for Special Surgery in New York City has received a $5.6 million grant from The Tow Foundation to establish the Hospital for Special Surgery Genomics Center.

25 Apr 2013

Vesicular stomatitis virus spares non-cancerous cells and kills melanoma cells

Researchers from Yale University School of Medicine have demonstrated that vesicular stomatitis virus (VSV) is highly competent at finding, infecting, and killing human melanoma cells, both in vitro and in animal models, while having little propensity to infect non-cancerous cells.

25 Apr 2013

Convergence starts Phase II proof of concept study with CNV2197944 in pain associated with PHN

Convergence Pharmaceuticals Limited, the company focused on the development of novel and high value analgesic medicines for the treatment of chronic pain, today announces that it has started a Phase II proof of concept study with CNV2197944 in pain associated with post-herpetic neuralgia.

24 Apr 2013

Nanogels to attack lupus: an interview with Dr Look and Dr Fahmy, Yale University

Nanogels are synthetic particles that can be used for drug delivery. They are approximately 100 nm to 200 nm in diameter, and are made from safe, biocompatible materials: a gel-like interior and a lipid exterior.

24 Apr 2013

FDA grants orphan-drug designation to XEN402 for treatment of pain associated with EM

Teva Pharmaceutical Industries Ltd. and Xenon Pharmaceuticals Inc. announced today that the US Food and Drug Administration has granted orphan-drug designation to the investigational drug XEN402 being developed for the treatment of pain associated with erythromelalgia.

24 Apr 2013

CNIO researcher-led consortium to receive MRA grant to advance research in melanoma

A consortium led by the Spanish National Cancer Research Centre's researcher Mar-a S. Soengas −Programme Director of the Centre-s Molecular Pathology Programme and Leader of the CNIO Melanoma Group− has been selected to receive funding from the Melanoma Research Alliance, the most important private international melanoma research foundation, in order to advance research in melanoma; this type of skin tumour represents one of oncology's biggest challenges due to its high incidence and malignancy.

24 Apr 2013

Research: Skin's immune cell plays a role in fighting off parasitic invaders

Sydney researchers have discovered a new type of immune cell in skin that plays a role in fighting off parasitic invaders such as ticks, mites, and worms, and could be linked to eczema and allergic skin diseases.

23 Apr 2013

Nuvo Research reaches another milestone with the launch of Pliaglis in Europe

Nuvo Research Inc., a specialty pharmaceutical company dedicated to building a portfolio of products for the topical treatment of pain and Galderma Pharma, S.A., today announced the European launch of Pliaglis (lidocaine and tetracaine) Cream 7%/7%.

23 Apr 2013

Researchers urge doctors to consider Lyme disease as cause when presented with skin lesions

When a person contracts Lyme disease, quick diagnosis and treatment are essential to avoiding long term complications. But the diagnostic process may be delayed if a physician does not recognize a skin rash caused by Lyme disease because it does not have the bull's-eye appearance that is best known to physicians and the public.

23 Apr 2013

Repeated plastic surgery required for dog bites to the face in children: Report

Dog bites to the face are a relatively common injury in young children, and often require repeated plastic surgery procedures to deal with persistent scarring, according to a report in the March Journal of Craniofacial Surgery, published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.

23 Apr 2013

Eating mushrooms can help increase, maintain vitamin D levels, find BUSM researchers

Researchers from Boston University School of Medicine have discovered that eating mushrooms containing Vitamin D2 can be as effective at increasing and maintaining vitamin D levels (25-hydroxyvitamin D) as taking supplemental vitamin D2 or vitamin D3.

23 Apr 2013

IMRT gives better results in patients with early breast cancer

Intensity modulated radiotherapy gives better results than standard radiotherapy in patients with early breast cancer, according to results from a randomised trial presented today (Sunday) to the 2nd Forum of the European Society for Radiotherapy and Oncology.

23 Apr 2013

Skin News and Research

Rexceptor receives exclusive license for novel treatment of Alzheimer's disease

Microbial population in New York City subway system is nearly identical to that of ambient air on city streets

Caliper test reliable for feet

Transcranial magnetic stimulation benefits in Parkinson’s disease

Symposium presentation highlights pioneer of gastrointestinal research

Hospital for Special Surgery receives grant for new genomics center to study autoimmune diseases

Vesicular stomatitis virus spares non-cancerous cells and kills melanoma cells

Convergence starts Phase II proof of concept study with CNV2197944 in pain associated with PHN

Nanogels to attack lupus: an interview with Dr Look and Dr Fahmy, Yale University

FDA grants orphan-drug designation to XEN402 for treatment of pain associated with EM

CNIO researcher-led consortium to receive MRA grant to advance research in melanoma

Research: Skin's immune cell plays a role in fighting off parasitic invaders

Nuvo Research reaches another milestone with the launch of Pliaglis in Europe

Researchers urge doctors to consider Lyme disease as cause when presented with skin lesions

Repeated plastic surgery required for dog bites to the face in children: Report

Eating mushrooms can help increase, maintain vitamin D levels, find BUSM researchers

IMRT gives better results in patients with early breast cancer

Non-invasive brain surgery: an interview with Dr Andres Lozano, University of Toronto

Indoor tanning increases risk of non-melanoma skin cancer

Photoacoustic imaging helps preserve healthy nodes in patients with metastasized cancer

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News